Lebrikizumab-Lbkz
1 NDC across 1 manufacturer|0 Generic,1 Brand
Lebrikizumab-Lbkz is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $3 million on Lebrikizumab-Lbkz across 292 claims for 168 beneficiaries.
Lebrikizumab-Lbkz is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $1784.34 to $1784.34 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$1784.34 – $1784.34
per ML
7d Activity
avg -0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing LEBRIKIZUMAB-LBKZ
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EBGLYSS 250 MG/2 ML PEN | $1784.3443 per ML | -0.10% |
Frequently Asked Questions
What is Lebrikizumab-Lbkz used to treat?
Lebrikizumab-Lbkz is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Lebrikizumab-Lbkz?
In 2024, Medicare Part D spent $3 million on Lebrikizumab-Lbkz across 292 claims for 168 beneficiaries.
How many Lebrikizumab-Lbkz products are on the market?
The Lebrikizumab-Lbkz drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Lebrikizumab-Lbkz?
NADAC reference prices for Lebrikizumab-Lbkz range from $1784.3443 to $1784.3443 per ML.
Which manufacturers make Lebrikizumab-Lbkz?
1 manufacturer lists Lebrikizumab-Lbkz in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (1).
How has the price of Lebrikizumab-Lbkz changed recently?
Over the past 7 days, 0 Lebrikizumab-Lbkz NDCs rose and 1 fell, with a market-wide average change of -0.1%.